BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2025 9:23:03 AM | Browse: 11 | Download: 39
Publication Name World Journal of Clinical Oncology
Manuscript ID 108086
Country India
Received
2025-04-07 15:28
Peer-Review Started
2025-04-07 15:28
To Make the First Decision
Return for Revision
2025-04-16 10:43
Revised
2025-04-27 06:10
Second Decision
2025-06-03 02:53
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-06-03 11:57
Articles in Press
2025-06-03 11:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-07-11 02:38
Publish the Manuscript Online
2025-07-22 09:23
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Letter to the Editor
Article Title Rosmarinic acid as a targeted modulator of NF-κB signaling in colorectal cancer: A promising adjunct to chemotherapy
Manuscript Source Invited Manuscript
All Author List Md Sadique Hussain, Amita Joshi Rana, Sumel Ashique, Vikash Jakhmola and Gaurav Gupta
ORCID
Author(s) ORCID Number
Md Sadique Hussain http://orcid.org/0000-0002-3554-1750
Amita Joshi Rana http://orcid.org/0000-0003-1907-4459
Sumel Ashique http://orcid.org/0000-0003-4362-2830
Vikash Jakhmola http://orcid.org/0000-0002-8108-006X
Gaurav Gupta http://orcid.org/0000-0001-7941-0229
Funding Agency and Grant Number
Corresponding Author Md Sadique Hussain, Assistant Professor, PhD, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Prem Nagar, Dehra Dun 248007, Uttarākhand, India. sadiquehussain007@gmail.com
Key Words Apoptosis; Combination chemotherapy; Drug resistance; Phytochemicals; Rosmarinic acid
Core Tip This Letter to the Editor underscores the novel findings by Liu et al, revealing rosmarinic acid (RA)’s role in inhibiting colorectal cancer (CRC) progression via NF-κB signaling suppression and its potential as a natural, safe chemosensitizer against 5-fluorouracil and oxaliplatin resistance. We underscore the therapeutic relevance of these findings, emphasizing RA’s potential as a safe, natural chemosensitizer in CRC treatment and its promising role in overcoming chemoresistance through modulation of inflammation-driven tumor pathways.
Publish Date 2025-07-22 09:23
Citation <p>Hussain MS, Rana AJ, Ashique S, Jakhmola V, Gupta G. Rosmarinic acid as a targeted modulator of NF-κB signaling in colorectal cancer: A promising adjunct to chemotherapy. <i>World J Clin Oncol</i> 2025; 16(7): 108086</p>
URL https://www.wjgnet.com/2218-4333/full/v16/i7/108086.htm
DOI https://dx.doi.org/10.5306/wjco.v16.i7.108086
Full Article (PDF) WJCO-16-108086-with-cover.pdf
Manuscript File 108086_Auto_Edited_061754.docx
Answering Reviewers 108086-answering-reviewers.pdf
Audio Core Tip 108086-audio.mp3
Conflict-of-Interest Disclosure Form 108086-conflict-of-interest-statement.pdf
Copyright License Agreement 108086-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 108086-non-native-speakers.pdf
Peer-review Report 108086-peer-reviews.pdf
Scientific Misconduct Check 108086-scientific-misconduct-check.png
Scientific Editor Work List 108086-scientific-editor-work-list.pdf
CrossCheck Report 108086-crosscheck-report.pdf